For investors looking for a "safe haven" during this historic market fluctuation... you need to look no further than this one-stop investment - that protects your purchasing power by diversifying your money and risk through this one single vehicle. Click here for all the details...
by The Investment U Research Team
In a rare bit of truly positive earnings, Starbucks (Nasdaq: SBUX) announced that it earned $151 million in the third quarter compared to a loss of $6.7 million last year. This news sent the shares up over 10%.
Even as overall sales were down, Starbucks’ focus on efficiency and cost savings at ever level has helped the bottom line – combined with store closings of almost 700 locations. These changes, combined with others, have started trickling down into its results.
Starbucks has been aggressively looking to change its image on a couple fronts. Starbucks gave away free pastries earlier this week, and is looking at natural products as well.
It’s also been looking to its stronghold Seattle market to test new store concepts that involve adding beer and wine at Starbucks’ stores. And in other locations, removing the ubiquitous Starbucks branding to give the appearance of more affordable local coffee shops.
We’ve been watching this stock since the return of CEO and founder Howard Shultz earlier this year. And it looks like he’s starting to gain some real momentum in making positive changes.
If this keeps up, he’ll bring the company back to its roots and its stock glory days of almost $40 a share.
Symbols mentioned in this article: SBUX.
- Starbucks (Nasdaq: SBUX): Don’t Sip On This Stock Just Yet
- Understanding Earnings Surprises: What to Look For & Their Meaning For Investors
- Whole Foods (Nasdaq: WFMI): Stock of the Day
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed